Meloxicam : influence of the dose

• 341 patients with RA treated with 15 mg meloxicam daily for up to 18 months (66%)

• 28% experienced GI adverse events

• 13.7% discontinued for adverse events

• 3.9% discontinued for GI adverse events

• 0.8% serious GI complications

Huskisson EC et al, BJR, 1996, 35 (Suppl.1) 29-34

Previous slide

Next slide

Back to first slide

View graphic version